HomeCompareZEST vs PFE

ZEST vs PFE: Dividend Comparison 2026

ZEST yields 1148.77% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZEST wins by $63788034.41M in total portfolio value
10 years
ZEST
ZEST
● Live price
1148.77%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63788034.46M
Annual income
$54,461,942,755,161.91
Full ZEST calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ZEST vs PFE

📍 ZEST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZESTPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZEST + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZEST pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZEST
Annual income on $10K today (after 15% tax)
$97,645.03/yr
After 10yr DRIP, annual income (after tax)
$46,292,651,341,887.62/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ZEST beats the other by $46,292,651,319,567.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZEST + PFE for your $10,000?

ZEST: 50%PFE: 50%
100% PFE50/50100% ZEST
Portfolio after 10yr
$31894017.26M
Annual income
$27,230,971,390,710.32/yr
Blended yield
85.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ZEST
No analyst data
Altman Z
-32.8
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZEST buys
0
PFE buys
0
No recent congressional trades found for ZEST or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZESTPFE
Forward yield1148.77%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$63788034.46M$49.6K
Annual income after 10y$54,461,942,755,161.91$26,258.71
Total dividends collected$63088458.04M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZEST vs PFE ($10,000, DRIP)

YearZEST PortfolioZEST Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$125,577$114,876.51$9,153$693.39+$116.4KZEST
2$1,482,572$1,348,204.74$8,593$849.25+$1.47MZEST
3$16,462,118$14,875,766.24$8,336$1,066.78+$16.45MZEST
4$171,985,424$154,370,957.54$8,437$1,384.80+$171.98MZEST
5$1,691,282,947$1,507,258,543.85$9,013$1,875.40+$1691.27MZEST
6$15,662,187,020$13,852,514,266.65$10,306$2,680.72+$15662.18MZEST
7$136,647,989,035$119,889,448,923.67$12,820$4,101.38+$136647.98MZEST
8$1,123,783,708,988$977,570,360,720.32$17,673$6,826.70+$1123783.69MZEST
9$8,715,973,556,473$7,513,524,987,855.93$27,543$12,591.86+$8715973.53MZEST
10$63,788,034,460,588$54,461,942,755,161.91$49,560$26,258.71+$63788034.41MZEST

ZEST vs PFE: Complete Analysis 2026

ZESTStock

Ecoark Holdings, Inc., through its subsidiaries, engages in the oil and gas, bitcoin mining, and post-harvest shelf-life and freshness food management technology businesses in the United States. It engages in the exploration, production, and drilling of oil and gas properties in Texas, Louisiana, and Mississippi, as well as offers transportation of frac sand and logistics services to hydraulic fracturing and drilling operations. The company also provides freshness management solutions for fresh food growers, suppliers, processors, distributors, grocers, and restaurants. In addition, it offers Zest Fresh solution, a cloud-based post-harvest shelf-life and freshness management solution that matches customer freshness requirements with actual product freshness and reduces post-harvest losses; and Zest Delivery solution, which provides real-time monitoring and control for prepared food delivery containers and helps delivery and dispatch personnel to ensure the quality and safety of delivered food. Further, the company is involved in the bitcoin mining operations; and procures and finances equipment to oilfield transportation service contractors. Ecoark Holdings, Inc. was founded in 2011 and is headquartered in San Antonio, Texas.

Full ZEST Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ZEST vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZEST vs SCHDZEST vs JEPIZEST vs OZEST vs KOZEST vs MAINZEST vs JNJZEST vs MRKZEST vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.